Treatment Resistant Neuromyelitis Optica Responsive to Anti IL-6 Immunotherapy

被引：0
|
作者：
Siwoski, Mark-Victor [1 ]
Lynch, Sharon G. [1 ]
机构：
[1] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P226
引用
收藏
页码：120 / 120
页数：1
相关论文
共 50 条
  • [1] Blockade of IL-6 signaling in neuromyelitis optica
    Araki, Manabu
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2019, 130
  • [2] Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options
    Rosso, Mattia
    Saxena, Shrishti
    Chitnis, Tanuja
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (05) : 509 - 516
  • [3] Satralizumab: an interleukin-6 (IL-6) receptor antagonist for the treatment of neuromyelitis optica spectrum disorders
    Paton, D. M.
    [J]. DRUGS OF TODAY, 2021, 57 (03) : 209 - 218
  • [4] Elevated IL-6 levels in the cerebrospinal fluid of neuromyelitis optica patients
    Tuzun, Erdem
    Akman-Demir, Gulsen
    Icoz, Serma
    Kurtuncu, Murat
    Eraksoy, Mefkure
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 179 - 180
  • [5] The Expression of IL-6 in The Central Nervous Tissue of Neuromyelitis Optica Spectrum Disorders
    Takai, Y.
    Misu, T.
    Namatame, C.
    Mastumoto, Y.
    Ono, H.
    Kaneko, K.
    Takahashi, T.
    Nishiyama, S.
    Kuroda, H.
    Aoki, M.
    Fujihara, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP78 - NP79
  • [6] CSF IL-6 study in neurological disorders with a special focus on Neuromyelitis optica
    Uzawa, A.
    Mori, M.
    Masuda, H.
    Ohtani, R.
    Uchida, T.
    Sawai, S.
    Kuwabara, S.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 909 - 909
  • [7] Clinical efficacy of anti-IL-6 receptor monoclonal antibody tocilizumab for the treatment of neuromyelitis optica
    Araki, M.
    Matsuoka, T.
    Aranami, T.
    Nakamura, M.
    Okamoto, T.
    Murata, M.
    Miyake, S.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 947 - 947
  • [8] A Complex Hyperkinetic Movement Disorder Responsive to Immunotherapy in a Patient with Neuromyelitis Optica
    Aguiar, Rafaela F.
    Nobrega, Paulo R.
    Veras, Samuel Ranieri O.
    Maia, Fernanda M.
    Sobreira-Neto, Manoel A.
    Braga-Neto, Pedro
    [J]. MOVEMENT DISORDERS CLINICAL PRACTICE, 2020, 7 (06): : 695 - 697
  • [9] How does anti-IL-6 receptor monoclonal antibody tocilizumab treatment ameliorate neuromyelitis optica?
    Matsuoka, T.
    Araki, M.
    Yamaguchi, H.
    Sato, W.
    Miyamoto, K.
    Kusunoki, S.
    Gold, R.
    Yamamura, T.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 1000 - 1001
  • [10] Relapsing neuromyelitis optica responsive to glatiramer acetate treatment
    Gartzen, K.
    Limmroth, V.
    Putzki, N.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (06) : E12 - E13
12345